In the tumor microenvironment, the increased platelets and the presence of cancer-associated anemia can induce angiogenesis by stimulating vascular endothelial growth factor (VEGF) and upregulating hypoxia inducible factor-1α (HIF-1α), which has significant role in cancer progression. Here, HIF1A is linked to anemia.